Patient Participation
Conditions
Keywords
Online Patient Portal
Brief summary
Based on the outcomes of the initial study (NCT05348603), this optimization study will employ the most effective interventions (letters and messages) and distribute these communications to underrepresented minorities to further promote interest in research. Optimized language will be distributed in English, Spanish, Portuguese, Chinese, Arabic, or Haitian Creole, based on preferred language identified in the patient profile in an electronic medical records system.
Detailed description
The primary objective of the optimization study is to examine the effectiveness on increasing interest in research of an optimized letter versus a generic letter; an optimized message versus a generic message; and an optimized letter and an optimized message versus a generic letter and a generic message. The secondary objective of the optimization study is to examine the effectiveness on increasing participation in research of an optimized letter versus a generic letter, an optimized message versus a generic message, an optimized letter and an optimized message versus a generic letter and a generic message.
Interventions
OTHERDirect to Patient Message - Optimized
Patients receive an optimized direct to patient message via the portal.
OTHEROptimized Letter
Patients receive an optimized letter.
OTHERTraditional Letter
Patients receive a traditional letter.
Patients receive a direct to patient message via the portal.
Sponsors
Food and Drug Administration (FDA)
Yale University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Has an account with the online patient portal * Has logged into the online patient portal at least once in the past year * Has not set up a research profile
Exclusion criteria
* Currently enrolled in a clinical trial * Opted out of research * On active cancer treatment * Active member of the study team
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of patients who create a research profile | 12 months | The outcome will be assessed by querying the patient's electronic medical record to determine whether the patient has registered in the Yale University Volunteer Database. This database is comprised of patients who agree to be contacted if there is a study at Yale that meets their interests. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of patients who enroll in a research study | 12 months | The outcome will be assessed by querying our clinical trials management system or electronic health record system to determine if the patient has consented to participate in a research study. |
Countries
United States
Outcome results
None listed